Skip to content
healthcare.dev

Deflazacort Oral Suspension

NDC 57664-993, Deflazacort Oral, suspension, from Sun Pharmaceutical Industries, Inc..

Product NDC
57664-993
Status
Listed
Labeler
Sun Pharmaceutical Industries, Inc.
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA219930
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/57664-993 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEFLAZACORT22.75 mg/mL

Pharmacologic classes

Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]

Package NDCNDC-11Package
57664-993-015766409930113 mL in 1 BOTTLE (57664-993-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2fac1332-0247-1047-e063-6294a90a557f

Use it

Look up 57664-993 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/57664-993 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 57664-993. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.